Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative

Six months after the publication of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) sequence, a record number of vaccine candidates were listed, and quite a number of them have since been approved for emergency use against the novel coronavirus disease 2019 (COVID-19). This unpreced...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Isaac Kyei-Barffour, Samuel Akwetey Addo, Enoch Aninagyei, George Ghartey-Kwansah, Desmond Omane Acheampong
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/bf7b697a21b34619b8042c67ff89a092
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!